Alprazolam Completed Phase 4 Trials for Anxiety Disorders Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT00703885PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)